PVLA
Palvella Therapeutics, Inc
137.90$
-0.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -45.3% | +98.9% | +333.5% | +15.1% | +59.0% | -36.6% | +7.1% | -17.6% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | +17.4% | – | – | – | |
| – | – | – | – | – | – | – | -0.9% | -20.4% | – | – | – | |
| – | +36.5% | +157.7% | +11.3% | +86.7% | +32.9% | -18.7% | +45.2% | -21.8% | -82.5% | -7.3% | +180.2% | |
| – | – | – | – | – | – | – | – | – | -26.0% | +93.2% | +165.2% | |
| – | +28.8% | +79.7% | +39.9% | +50.3% | +22.0% | -15.6% | +32.3% | -17.7% | -82.2% | +18.8% | +173.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +34.8% | |
| – | – | – | – | – | – | – | – | – | – | -193.3% | – | |
| – | – | -20.6% | +581.0% | -128.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -193.3% | – | |
| – | – | – | – | – | – | – | – | – | – | -170.2% | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.